Objective To explore the effects of nebulized acetylcysteine solution combined with pediatric throat clearing and antipyretic oral solution on Forced Expiratory Volume in 1 second(FEV1), Forced Vital Capacity(FVC), and Maximal Mid-Expiratory Flow(MMEF) levels in children with bronchopneumonia. Methods A retrospective study was conducted on 104 children with bronchopneumonia admitted to the Maternal and Child Health Hospital of Nan'an City from July 2023 to October 2024. The children were divided into a control group (n=52) and a combination group (n=52) based on different treatment methods. The control group was treated with nebulized acetylcysteine solution, while the combination group received additional pediatric throat clearing and antipyretic oral solution on the basis of the control group's treatment. Compare and contrast the relevant indicators. Results The levels of lung function and clinical symptoms to disappear in the combination group after treatment were better than those in the control group (P<0.05). In terms of safety assessment, the overall incidence of adverse reactions in each group of children showed no statistically significant difference (P>0.05). Conclusions The combination of nebulized acetylcysteine solution and pediatric throat clearing and antipyretic oral solution can improve the lung function indicators FEV1, FVC, and MMEF levels in children with bronchopneumonia, with a faster recovery time and good safety.
Key words
Pediatric bronchopneumonia /
Inhalation acetylcysteine solution /
Children's throat clearing and antipyretic oral solution /
Lung function
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Becker B,Morgenroth K,Reinhardt D,et al.The dyskinetic cilia syndrome in childhood. Modifications of ultrastructural patterns[J]. Respiration,1984,46(2):180-186.
[2] Evaristus AE,Chizaram NI,Ugochukwu US,et al.Bronchial Foreign Body Mimicking Chronic Cough and Recurrent Bronchopneumonia:Diagnostic Dilemma in a Resource Poor Setting[J]. Orient J Med,2023,35(3/4):69-74.
[3] 李冰,王慧琴,万燕明,等. 吸入用乙酰半胱氨酸溶液联合重组人干扰素α2b雾化吸入治疗小儿病毒性肺炎50例疗效观察[J]. 安徽医药,2023,27(9):1874-1876.
[4] 中华中医药学会发布. 中医儿科常见病诊疗指南[M]. 北京:中国中医药出版社,2012.
[5] 胡亚美. 诸福棠实用儿科学[M].北京:人民卫生出版社,2002.
[6] Huang X,Gu H,Wu R,et al.Chest imaging classification in Mycoplasma pneumoniae pneumonia is associated with its clinical features and outcomes[J]. Respir Med,2024,221:107480.
[7] 韩会德. 乙酰半胱氨酸联合布地奈德治疗小儿肺炎的效果及对免疫功能的影响[J]. 妇儿健康导刊,2024,3(13):105-108.
[8] 叶冰. 儿童清咽解热口服液联合头孢克洛治疗小儿急性细菌性上呼吸道感染的临床效果[J]. 妇儿健康导刊,2023,2(21):78-80.
[9] 黄翠珍. 儿童清咽解热口服液联合克拉霉素治疗急性上呼吸道感染的临床观察[J]. 中外医学研究,2024,22(27):50-52.
PDF(578 KB)
